|
ATG12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.178500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.462100E-02 |
| Normal-vs-Stage2 |
4.358400E-02 |
| Normal-vs-Stage3 |
9.178500E-03 |
| Normal-vs-Stage4 |
8.507800E-02 |
| Stage1-vs-Stage2 |
1.595790E-01 |
| Stage1-vs-Stage3 |
1.168950E-01 |
| Stage1-vs-Stage4 |
1.652390E-01 |
| Stage2-vs-Stage3 |
9.529800E-01 |
| Stage2-vs-Stage4 |
3.329600E-01 |
| Stage3-vs-Stage4 |
3.780400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.061700E-02 |
| Normal-vs-AfricanAmerican |
5.881500E-03 |
| Normal-vs-Asian |
1.941850E-03 |
| Caucasian-vs-AfricanAmerican |
4.605800E-01 |
| Caucasian-vs-Asian |
1.723840E-01 |
| AfricanAmerican-vs-Asian |
2.212600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.260090E-02 |
| Normal-vs-Female |
3.351200E-04 |
| Male-vs-Female |
9.394100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.411500E-02 |
| Normal-vs-Extreme_Weight |
4.673800E-02 |
| Normal-vs-Obese |
1.296060E-02 |
| Normal-vs-Extreme_Obese |
4.044600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.822800E-01 |
| Normal_Weight-vs-Obese |
9.305400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.498980E-01 |
| Extreme_Weight-vs-Obese |
3.973600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.047210E-01 |
| Obese-vs-Extreme_Obese |
7.438400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.238100E-03 |
| Normal-vs-Age(41-60Yrs) |
5.8037999999927E-05 |
| Normal-vs-Age(61-80Yrs) |
1.807750E-01 |
| Normal-vs-Age(81-100Yrs) |
4.148600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.973800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.276820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.971800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.121780E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.374000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.573000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.321500E-02 |
| Normal-VS-Type2 PRCC |
8.221000E-03 |
| Normal-VS-KIRP CIMP |
7.324400E-03 |
| Normal-VS-Unclassified PRCC |
6.846100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.804600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.724400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.550400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.655800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.602000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.111400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.964100E-02 |
| Normal-vs-N1 |
1.718260E-02 |
| Normal-vs-N2 |
1.041680E-03 |
| N0-vs-N1 |
1.765560E-01 |
| N0-vs-N2 |
1.489250E-01 |
| N1-vs-N2 |
6.745600E-01 |
|
|
